Celecoxib, the brand name for Celebrex, is an oral selective COX-2 inhibitor that is primarily used to treat ulcerative colitis and other conditions characterized by inflammation and damage to the intestinal mucosa. It belongs to the selective COX-2 inhibitor drugs class and is commonly used for its dual relief of inflammation and pain associated with ulcerative colitis and other conditions.
The global Celecoxib market has been experiencing significant growth. As of 2023, the market size was valued at USD 904.18 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of a significant increase.
The Asia Pacific region is a major driver of the Celecoxib market's growth. China's growth is expected to keep upwardforce in place as the Asia-Pacific region is the largest market for Celecoxibs per a few key figures:
Viatris Pharmacy is in the early stages of study of potential OTC products and is involved in the analysis and marketing of Celecoxib. GlaxoSmithKline, a player in the gastrointestinal tract market, is expanding its product range and actively looks for new partners.
The cost of Celebrex will remain an important key consideration for those looking to manage their conditions. The cost of Celebrex pills in the global market will be around USD compr10 to USD 1 per pill. This cost will increase to USD 10 to USD 100 per pill for certain patient based on factors such as the dosage, frequency of use, and the need for continued care. The COX-2 inhibitors will be priced differently in the different countries, with some pharmaceutical prices varying depending on factors such as country, quantity purchased, and price competition from cheaper generics.
The cost of Celecoxib pills in the global market will be around USD150 to USD USD 200. This cost will increase to USD USD 300 per pill in certain countries. The availability of multiple convenient options and multiple sclerosis medicines are also driving demand;
The Asia-Pacific region is a major driver of the Celecoxib market's growth.
Alternate Name:Celebrex
Description:Celecoxib is prescribed if your pain makes you stand out as a unique or stubborn case of pain. It is used to treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute pain. The generic alternative is Xeljanz. Both drugs are prescribed for pain. For some patients, the generic alternative can lead to serious side effects such as muscle pain, stiffness, or even an unusual cough. Xeljanz is prescribed for acute pain, which is usually caused by inflammation in the spasticity. In these cases, Xeljanz can lead to serious side effects such as muscle pain, stiffness, or even an unusual cough. Both Xeljanz and Celebrex are used for other conditions as determined by the appropriateness of the particular medication. Consult your healthcare professional before taking any new medications and for a longer term, if you wish to consult for Xeljanz.
Dosage Form:Single Tablet
Administration:For adults with acute pain where a generic alternative is indicated, the usual dose is 100 to 200 mg once daily. For adolescents, the usual dose is 10 to 30 mg once daily. Generally, the dose is administered as a single daily tablet. Dosages up to 800 mg/day are also available. Xeljanz is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. Inform your doctor about your medical history and the potential risks and side effects of Xeljanz before taking this medication.
Drug Interactions:Inform your doctor if you are taking any of the following medications: gabapentin, topiramate, lithium, rifampin, phenytoin, phenobarbital, rifampicin, carbamazepine, or phenytoin.
Use/Dosage/Usage/Overdose:Report to your doctor immediately any symptoms of dizziness, lightheadedness, tingling in the ankles and feet, headache, muscle weakness, and irregular heartbeats. Do not drive, use machinery, or do any activity with drowsor activity such as climbing, twisting, or punching. Drowsor activity may cause severe dizziness, lightheadedness, fainting, or cardiovascular collapse. Do not lie down for at least 10 minutes after the dose. If you are an older patient, call your doctor for medical advice. Your doctor will probably tell you not to lie down for at least 10 minutes after the dose. Tell your doctor immediately if you have chest pain, shortness of breath, or dizziness, especially if you are an older patient. Do not drive, use machinery, or do any activity with drowsor activity. Drowsor activity increases the risk of seizures. Tell your doctor immediately if you have a seizure for at least 30 minutes. Tell your doctor that you are taking diclofenac.
You have two options to use Xeljanz:Note:it is not recommended for use by more than 1 in 100 patients with osteoarthritis or rheumatoid arthritis; the usual effective dose is 10 to 20 mg/day. Xeljanz may be used off-label for other conditions as determined by the physician.
Using Xeljanz during pregnancy can harm a developing fetus. Xeljanz has not been studied in pregnant women as it is not FDA-approved for this use. It is generally not recommended for use during pregnancy because of potential teratogenic effects on the developing fetus. Xeljanz has not been studied in breastfeeding women. It is generally not recommended for use during pregnancy.A new study by the University of Illinois found that a drug, called, reduced inflammation associated with an allergic reaction, and that this effect was greater in people who took Celebrex. This means that a drug like Celebrex can help relieve pain and swelling in the joints, which is why they are called arthritis pain relievers.
In the study, published in the Journal of the American Medical Association, the researchers evaluated the effectiveness of Celebrex in relieving joint pain.
The drug was developed by AstraZeneca.
The study, led by Dr. Lisa G. Ricks, a team leader in internal medicine at the University of Illinois at Chicago, was conducted over a four-year period at five high-functioning academic medical centers. The researchers examined a total of 100 patients who were assigned to either receive a 2.5 mg, 5 mg, 10 mg, 15 mg, or 30 mg of Celebrex.
Dr. G. Ricks said that although patients were treated with the lowest dose of Celebrex, they were still receiving the lowest dose of Celebrex for the entire treatment period. This means that if Celebrex were to be effective, the drug would likely be more effective in alleviating pain, compared to the lowest dose of Celebrex.
The researchers said that the overall effect of this study was relatively small and that some of the results may be attributable to the small sample size.
The researchers concluded that the drug was an effective treatment for arthritis pain, with no serious adverse events.
"A drug like Celebrex can be used to relieve pain and swelling in joints and other non-inflammatory conditions," said Dr. Ricks. "We are pleased with the results, and hope that the study will inform future generations to be more comfortable and aware of their arthritis needs."
Ricks said that her research was supported by the American College of Physicians and the National Institutes of Health, as well as the National Formulary of the National Prescribing Information.
In addition, the study was published in the New England Journal of Medicine.
The National Institute of Aging sponsored the study. The researchers were led by Dr. Susan H. Minkowski, director of the Institute of Medicine.
Ricks said that her research was supported by the National Institutes of Health.
— (c) 2013, January 12, 2017Photo: U. S. Public Library/Getty ImagesThe researchers, led by Dr. Lisa Ricks, a professor of internal medicine at the University of Illinois at Chicago, conducted a controlled study on Celebrex (celecoxib) use among healthy volunteers.
The study used data from a large, population-based study in the United States. Participants were selected based on the criteria of having experienced pain for more than two years, taking anti-inflammatory medications (celecoxib, ibuprofen, or naproxen) and having an increased need for joint replacement (Celebrex).
The researchers also looked at the effects of taking Celebrex at the lowest dose in comparison with taking a higher dose for at least two years. Patients taking Celebrex received a 2.5 mg, 5 mg, 10 mg, 15 mg, or 30 mg dose, respectively, for up to two years.
The researchers found that taking a higher dose of Celebrex (5 mg for up to two years) had no significant adverse events.
The study was presented at the annual meeting of the American College of Physicians, and was funded by AstraZeneca.
This is an extended version of a statement from AstraZeneca on the company’s Web site.
The study was published in the Journal of the American Medical Association in May.
The researchers noted that the results do not confirm or refute a finding by the researchers that taking a higher dose of Celebrex for at least two years was associated with an increased risk of osteoporosis and fractures. The researchers also noted that their results were based on a retrospective study of a larger sample of arthritis patients.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$8.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Prices| Brand | Quantity | Cost |
|---|---|---|
| Celebrex (100mg) | 60 capsules | $15.50 |
| Celebrex (60mg) | ||
| Celecoxib (100mg) | $24.90 | |
| Celecoxib (60mg) | $29.20 |
Product specifications are as follows:
Buybursement method is by cash or credit card. Arbalen is available as a supply fee and an eligible quantity. Arbalen is typically taken as a single dose of 50mg. If your quantity is over $200 you may be eligible forbursement. Arbalen is usually taken as a single dose of 100mg. If your quantity is over $300 you may be eligible forbursement. Arbalen is usually taken as a single dose of 50mg.
Stade de France Pharmacy